FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Nanobeak LLC 		2. Issuer Name and Ticker or Trading Symbol

Vantage Health [ VNTH ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

3 COLUMBUS CIRCLE,, 15TH FLOOR 		3. Date of Earliest Transaction (MM/DD/YYYY)

12/15/2014
(Street)

NEW YORK, NY 10019
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   12/15/2014     A    100000   A $0.050   112100000   D   (1)  
Common Stock   12/16/2014     A    100000   A $0.041   112200000   D   (1)  
Common Stock   12/17/2014     A    100000   A $0.045   112300000   D   (1)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  Shares are owned directly by Nanobeak LLC, a ten percent owner of the issuer, and indirectly by Jeremy Barbera as the majority shareholder, director and executive officer of Nanobeak LLC. Jeremy Barbera exercises sole voting and dispositive power of the 112,300,000 shares of common stock beneficially owned by Nanobeak LLC.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Nanobeak LLC
3 COLUMBUS CIRCLE,
15TH FLOOR
NEW YORK, NY 10019
X

BARBERA JEREMY
C/O NANOBEAK LLC
3 COLUMBUS CIRCLE, 15TH FLOOR
NEW YORK, NY 10019
X


Signatures
/s/ Nanobeak LLC 12/18/2014
** Signature of Reporting Person Date

/s/ Jeremy Barbera 12/18/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Nano Mobile Healthcare (PK) Charts.
Nano Mobile Healthcare (PK) (USOTC:VNTH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Nano Mobile Healthcare (PK) Charts.